HRHabiba I. Mbbs Ramon-Yusuf

Habiba I. Mbbs Ramon-Yusuf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Habiba I. Mbbs Ramon-Yusuf has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Comprehensive review of current management guidelines of chronic kidney disease

    by Chukwuka Elendu, Rhoda C. Mbbs Elendu, Joy M. Mbbs Enyong, Jennifer O. Mbbs Ibhiedu, Ibukunoluwa V. Mbbs Ishola, Emmanuel O. Mbbs Egbunu, Emmanuel S. Mbbs Meribole, Sodiq O. Mbbs Lawal, Chinazo J. Mbbs Okenwa, Geraldine C. B.Tech Okafor, et al.

    Chronic kidney disease (CKD) is a prevalent and progressive condition affecting millions worldwide. It is a long-term condition characterized by gradual loss of kidney function over time. The management of CKD is complex and requires a multidisciplinary approach. This review aims to outline the current management guidelines for CKD. The study included a comprehensive search of various PubMed, Embase, and the Cochrane Library databases for articles published between 2010 and 2023. The search terms used were "chronic kidney disease," "management," and "guidelines." The inclusion criteria were articles that provided management guidelines for patients with CKD. A total of 23 articles were included in the review. Most articles were based on the Kidney Disease Improving Global Outcomes guidelines, the most widely recognized and used guidelines for managing CKD. The study found that the guidelines emphasize the importance of early detection and management of CKD and the need for an approach that involves multiple disciplines in its management. The guidelines recommend several interventions to slow the progression of CKD, including blood pressure control, glycemic control in diabetic patients, and reduce proteinuria. Other interventions include lifestyle modifications such as dietary changes, physical activity, and smoking cessation. The guidelines also recommend regular monitoring of kidney function and referral to a nephrologist for patients with advanced CKD or other complications. Overall, the current management guidelines for CKD emphasize the importance of early detection and a multidisciplinary approach to its management.


  • Open Access

    Comprehensive review of diabetic ketoacidosis: an update

    by Chukwuka Elendu, Johnson A. Mbbs David, Abasi-O. Mbbs Udoyen, Emmanuel O. Mbbs Egbunu, Ifeanyichukwu C. Mbbs Ogbuiyi-Chima, Lilian O. Mbbs Unakalamba, Awotoye I. Mbbs Temitope, Jennifer O. Mbbs Ibhiedu, Amos O. Mbbs Ibhiedu, Promise U. Mbbs Nwosu, et al.

    The most frequent hyperglycemic emergency and the leading cause of death in people with diabetes mellitus is diabetic ketoacidosis (DKA). DKA is common in people with type 1 diabetes, while type 2 diabetes accounts for roughly one-third of occurrences. Although DKA mortality rates have generally decreased to low levels, they are still significant in many underdeveloped nations. In industrialized countries, its mortality rate ranges from 2 to 5%, but in underdeveloped nations, it ranges from 6 to 24%. Therefore, it is always lethal if misdiagnosed or improperly treated. According to specific research, DKA can be present at the time of type 1 diabetes onset in 25 to 30% of cases and in 4 to 29% of young people with type 2 diabetes mellitus, and its features include hyperglycemia, metabolic acidosis, and ketosis with its triggering factors commonly being infections, newly discovered diabetes, and failure to start insulin therapy. Less than 20% of DKA patients present comatose, and patients with different levels of consciousness can present at other times. A close association between abnormalities found during a mental status evaluation and osmolality seems to exist. Hospital admission is necessary for vigorous intravenous fluid therapy, insulin therapy, electrolyte replacement, diagnosis and treatment of the underlying triggers, and routine monitoring of the patient’s clinical and laboratory conditions to manage DKA properly. Appropriate discharge plans should include actions to prevent a DKA recurrence and the proper selection and administration of insulin regimens.